Allozymes
Allozymes accelerates discovery and engineering of enzymes to deliver sustainable biosolutions for pharmaceuticals, chemicals, food & nutrition, and personal care. They combine a proprietary ultra-high-throughput microfluidics screening platform (capable of screening up to 20 million variants daily) with AI, machine learning, and computational design to identify and optimize enzyme variants. The company maintains a deep enzyme database (reported ~7 billion data points) and offers Enzyme Engineering Services, Biosolutions Licensing, and Database Access through ZymeLeap™. Allozymes also supports pilot-scale bioprocessing (up to 150L) to enable scale-up and commercialization for industrial customers.
Allozymes
Allozymes accelerates discovery and engineering of enzymes to deliver sustainable biosolutions for pharmaceuticals, chemicals, food & nutrition, and personal care. They combine a proprietary ultra-high-throughput microfluidics screening platform (capable of screening up to 20 million variants daily) with AI, machine learning, and computational design to identify and optimize enzyme variants. The company maintains a deep enzyme database (reported ~7 billion data points) and offers Enzyme Engineering Services, Biosolutions Licensing, and Database Access through ZymeLeap™. Allozymes also supports pilot-scale bioprocessing (up to 150L) to enable scale-up and commercialization for industrial customers.